Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer

Clinical Cancer Research

Volumn 5, Issue 5, 1999, Pages 1231-1240

  Xing, Eric Poe ^a   Yang, Guang Yu ^a   Wang, Li Dong ^b   Shi, Stephanie Tao ^a   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CHROMOSOME 13Q; ESOPHAGUS CANCER; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ALLELES; CARCINOMA, SQUAMOUS CELL; CHINA; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENES, RETINOBLASTOMA; HUMANS; LOSS OF HETEROZYGOSITY; MINISATELLITE REPEATS; NEOPLASM PROTEINS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RETINOBLASTOMA PROTEIN; RISK FACTORS; SEQUENCE DELETION;

EID: 0032957746     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A. Rapaport, J. M., Albert, D. M., and Dryja, T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (Lond.), 323: 643-646, 1986.
2. 1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
3. Chellappan, S. P., Hiebert, S., Mudryj, M., Horowitz, J. M., and Nevins, J. R. The E2F transcription factor is a cellular target for the RB protein. Cell, 65: 1053-1061, 1991.
4. Buchkovich, K., Duffy, L. A., and Harlow, E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell, 58: 1097-1105, 1989.
5. Johnson, D. G., Schwarz, J. K., Cress, W. D., and Nevins, J. R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature (Lond.), 365: 349-352, 1993.
6. Benedict, W. F., Xu, H. J., Hu, S. X., and Takahashi, R. Role of the retinoblastoma gene in the initiation and progression of human cancer. J. Clin. Invest., 85: 988-993, 1990.
7. Benedict, W. F., Xu, H. J., and Takahashi, R. The retinoblastoma gene: its role in human malignancies. Cancer Invest., 8: 535-540, 1990.
8. Knudson, A. G. Mutation and cancer in man. Cancer (Phila.), 39: 1882-1886, 1977.
9. Xu, H. J., Cairns, P., Hu, S. X., Knowles, M. A., and Benedict, W. F. Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. Int. J. Cancer, 53: 781-784, 1993.
10. Gouyer, V., Gazzeri, S., Brambilla, E., Bolon, I., Moro, D., Perron, P., Benabid, A. L., and Brambilla, C. Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuroendocrine lung carcinomas. Int. J. Cancer, 58: 818-824, 1994.
11. Tamura, K., Zhang, X., Murakami, Y., Hirohashi, S., Xu, H. J., Hu, S. X., Benedict, W. F., and Sekiya, T. Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer. Int. J. Cancer, 74: 45-49, 1997.
12. Borg, A., Zhang, Q. X., Alm, P., Olsson, H., and Sellberg, G. The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res., 52: 2991-2994, 1992.
13. Yoo, G. H., Xu, H-J., Brennan, J. A., Westra, W., Hruban, R. H., Koch, W., Benedict, W. F., and Sidransky, D. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res., 54: 4603-4606, 1994.
14. Pei, L., Melmed, S., Scheithauer, B., Kovacs, K., Benedict, W. F., and Prager, D. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res., 55: 1613-1616, 1995.
15. Peng, H. Q., Bailey, D., Bronson, D., Goss, P. E., and Hogg, D. Loss of heterozygosity of tumor suppressor genes in testis cancer. Cancer Res., 55: 2871-2875, 1995.
16. Boynton, R. F., Huang, Y., Blount, P. L. Reid, B. J., Raskind, W. H., Haggitt, R. C., Newkirk, C., Resau, J. H., Yin, J., McDaniel, T., and Meltzer, S. J. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res., 51: 5766-5769, 1991.
17. Huang, Y., Boynton, R. F., Blount, P. L., Silberstein, R. J., Yin, J., Tong, Y., McDaniel, T., K., Newkirk, C., Resau, J. H., Sridhara, R., Reid, B. J., and Meltzer, S. J. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res., 52: 6525-6530, 1992.
18. Zhang, X., Xu, H. J., Murakarni, Y., Sachse, R., Yashima, K., Hirohashi, S., Hu, S. X., Benedict, W. F., and Sekiya, T. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res., 54: 4177-4182, 1994.
19. Cordon-Cardo, C., Zhang, Z-F., Dalbagni, G., Drobnjak, M., Charytonowicz, E., Hu, S-X., Xu, H-J., Reuter, V. E., and Benedict, W. F. Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res., 57: 1217-1221, 1997.
20. Cote, R. J., Dunn, M. D., Chatterjee, S. J., Stein, J. P., Shi, S. R., Tran, Q. C., Hu, S. X., Xu, H. J., Groshen, S., Taylor, C. R., Skinner, D. G., and Benedict, W. F. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res., 58: 1090-1094, 1998.
21. Dosaka-Akita, H., Hu, S. X., Fujino, M., Harada, M., Kinoshita, I., Xu, H. J., Kuzumaki, N., Kawakami, Y., and Benedict, W. F. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis. Cancer (Phila.), 79: 1329-1337, 1997.
22. Ferron, P. E., Bagni, I., Guidoboni, M., Beccati, M. D., and Nenci, I. Combined and sequential expression of p53, Rb, Ras and Bcl-2 in bronchial preneoplastic lesions. Tumori, 83: 587-593, 1997.
23. Gleich, L. L., Li, Y. Q., Biddinger, P. W., Gartside, P. S., Stambrook, P. J., Pavelic, Z. P., and Gluckman, J. L. The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer. Laryngoscope, 706: 1378-1381, 1996.
24. Murakami, Y., Hayashi, K., Hirohashi, S., and Sekiya, T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res., 51: 5520-5525, 1991.
25. Wang, J., Coltrera, M. D., and Gown, A. M. Abnormalities of p53 and p110RB tumor suppressor gene expression in human soft tissue tumors: correlations with cell proliferation and tumor grade. Mod. Pathol., 8: 837-842, 1995.
26. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
27. Gotz, C. and Montenarh, M. p53. DNA damage, DNA repair, and apoptosis. Rev. Physiol. Biochem. Pharmacol., 127: 65-95, 1996.
28. Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., and Weinberg, R. A. Effects of an Rb mutation in the mouse. Nature (Lond.), 359: 295-300, 1992.
29. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215-221, 1992.
30. Williams, B. O., Remington, L., Albert, D. M., Mukai, S., Bronson, R. T., and Jacks, T. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat. Genet., 7: 480-484, 1994.
31. Haupt, Y., and Oren, M. p53-mediated apoptosis: mechanisms and regulation. Behring Inst. Mitt., 97: 32-59, 1996.
32. Macleod, K. F., Hu, Y., and Jacks, T. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J., 75: 6178-6188, 1996.
33. Cowell, J. K. The nuclear oncoproteins: RB and p53. Semin. Cancer Biol., 1: 437-446, 1990.
34. Levine, A. J. The p53 tumor suppressor gene and gene product. Princess Takamatsu, 20: 221-230, 1989.
35. Scheffner, M., Munder, K., Byrne, J. C., and Howley, P. M. The states of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA, 88: 5523-5527, 1991.
36. Xiao, Z. X., Chen, J., Levine, A. J., Modjtahedi, N., Xing, J., Sellers, W. R., and Livingston, D. M. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature (Lond.), 375: 694-698, 1995.
37. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
38. Gao, H., Wang, L. D., Zhou, Q., Hong, J-Y., Huang, T-Y., and Yang, C. S. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res., 54: 4342-4346, 1994.
39. Shi, T., Yang, G-Y, Wang, L. D. Z., Xue, Z., Feng, B., Ding, W., Xing, E. P., and Yang, C. S. Role of p53 gene mutation in human esophageal carcinogenesis: results from immunohistochemical and mutation analysis of carcinomas and nearby non-cancerous lesions. Carcinogenesis (Lond.), in press, 1999.
40. Yang, G-Y., Zhang, Z., Jie, L., Seril, D., Wang, L. D., Goldstein, S., and Yang, C. S. Immunohistochemical studies of Waf1p21, p16, pRb, and p53 in human esophageal carcinoma and neighboring epithelia from a high-risk area in northern China. Int. J. Cancer, 72: 746-751, 1997.
41. Wang, L. D., Shi, S. T., Zhou, Q., Goldstein, S., Hong, J. Y., Shao, P., Qiu, S. L., and Yang, C. S. Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. Int. J. Cancer, 59: 514-519, 1994.
42. Vogelstein, B., Fearon, E. R., Kern, S. E., Hamilton, S. R., Preisinger, A. C., Nakamura, Y., and White, R. Allelotype of colorectal carcinomas. Science (Washington DC), 244: 207-211, 1989.
43. Ashton-Rickardt, P. G., Wyllie, A. H., Bird, C. C., Dunlop, M. G., Steel, C. M., Morris, R. G., Piris, J., Romanowski, P., Wood, R., White, R., and Nakamura, Y. MCC, a candidate familial polyposis gene in 5q.21, shows frequent allele loss in colorectal and lung cancer. Oncogene, 6: 1881-1886, 1991.
44. Fong, C. T., Dracopoli, N. C., White, P. S., Merrill, P. T., Griffith, R. C., Housman, D. E., and Brodeur, G. M. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc. Natl. Acad. Sci. USA, 86: 3753-3757, 1989.
45. Bremner, R., Du, D. C., Connolly-Wilson, M. J., Bridge, P., Ahmad, K. F., Mostachfi, H., Rushlow, D., Dunn, J. M., and Gallie, B. L. Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma. Am. J. Hum. Genet., 61: 556-570, 1997.
46. Stirzaker, C., Millar, D. S., Paul. C. L., Warnecke, P. M., Harrison, J., Vincent, P. C., Frommer, M., and Clark, S. J. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res., 57: 2229-2237, 1997.
47. Meltzer, S. J. The molecular biology of esophageal carcinoma. Rec. Results Cancer Res., 142: 1-8, 1996.
48. INK4b are frequent events in human esophageal cancer in Linxian, China. Carcinogenesis (Lond.), 20: 77-84, 1998.
49. Osada, M., Ohba, M., Kawahara, C., Ishioka, C., Kanamaru, R., Katoh, I., Nimura, Y., Nakagawara, A., Obinata, M., and Ikawa, S. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat. Med., 4: 839-843, 1998.
50. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dotsch, V., Andrews, N. C., Caput, D., and McKeon, F. p63, a p53 homolog at 3p27, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell, 2: 305-316, 1998.